Table 1.
Clinical data of TAO active group, TAO inactive group, and control group
| Control group | TAO inactive phase group | TAO activity group | P value | |
|---|---|---|---|---|
| Cases | 32 | 38 | 40 | |
| Gender | 0.923& | |||
| Male | 8 (25%) | 9 (23.68%) | 9 (22.5%) | |
| Female | 24 (75%) | 29 (76.32%) | 31 (77.5%) | |
| Age (years) | 40.63 ± 8.12 | 36.5 ± 12.56 | 43.11 ± 8.02 | 0.071Φ |
| TAO course (months) | — | 46.83 ± 48.35 | 18.56 ± 14.63 | 0.008*Φ |
| Degree of exophthalmos (mm) | — | 17.77 ± 2.43 | 21.14 ± 3.58 | 0.000*Φ |
| CAS | — | 0.83 ± 0.84 | 4.47 ± 0.81 | 0.000*# |
| TAO severity degree | — | 0.000& | ||
| Light | — | 7 (18.42%) | 0 | |
| Medium | — | 31 (81.58%) | 8 (20%) | |
| Serious | — | 0 | 32 (80%) |
Data were presented as mean ± standard deviation or number (%). P-values were obtained using &χ2 tests for categorical variables; the #Kruskal–Wallis test or Φone-way ANOVA were used for continuous variables. The asterisk implies statistical significance.